We validated the FLRT3 results across benign, prostrate carcinoma and metastatic prostate cancer tissues by immunoblot analysis (Supplementary Fig. S14D) which confirmed the inverse correlation between P4HA1 and FLRT3. The gene discussed is FLRT3; the disease is metastatic prostate carcinoma.